EU to penalize Lundbeck, Ranbaxy and others for Blocking Generic Drugs
European regulators have clamped down on “pay-for-deals” in the pharmaceutical sector fining Denmark’s Lundbeck, India’s Ranbaxy and seven other drug manufacturing firms for limiting the access of cheap medicines to the market. 5th June 2013 A European regulator will penalize Denmark based Lundbeck ( LUN.CO), India’s No.1 pharmaceutical company Ranbaxy and seven other drug makers...